Trials / Withdrawn
WithdrawnNCT06536244
Impact of Perioperative Anesthetic Management on Renal Cancer Progression.
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- M.D. Anderson Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The relationship between perioperative drugs, including preoperative medications, anesthetics, and analgesics, and postoperative outcomes in cancer patients is a complex and evolving field of study. Understanding how those medications might impact outcomes such as pain, acute kidney injury, and recurrence is crucial for optimizing perioperative care in renal cancer patients.
Detailed description
This retrospective study will investigate the association of perioperative drugs on short and long-term postoperative outcomes in patients undergoing kidney surgeries for renal cell carcinoma.
Conditions
Timeline
- Start date
- 2020-07-31
- Primary completion
- 2026-09-01
- Completion
- 2028-09-01
- First posted
- 2024-08-02
- Last updated
- 2024-08-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06536244. Inclusion in this directory is not an endorsement.